Junctophilin-2  physically interacts with ryanodine receptor type 2 for peripheral coupling of mouse cardiomyocytes

2020 ◽  
Author(s):  
Tianxia Luo ◽  
Ningning Yan ◽  
Mengru Xu ◽  
Fengjuan Dong ◽  
Qian Liang ◽  
...  

Abstract Background: Ryanodine receptor type 2 (RyR2) mediate Ca 2+ release from the endoplasmic and sarcoplasmic reticulum (ER and SR), which is involved in the peripheral coupling of mouse cardiomyocytes, and thereby plays an important role in cardiac contraction. Junctophilin-2 (JPH2, JP2) is anchored to the plasma membrane (PM) and membranes of the ER and SR, and modulates intracellular Ca 2+ handling through regulation of RyR2. However, the potential RyR2 binding region of JPH2 is poorly understood. Methods: The interaction of JPH2 with RyR2 was studied using LC-MS/MS , bioinformatic analysis,co-immunoprecipitation studies in cardiac SR vesicles. GST-pull down analysis was performed to investigate the physical interaction between RyR2 and JPH2 fragments. Immunofluorescent staining was carried out to determine the colocalization of RyR2 and JPH2 in isolated mouse cardiomyocytes. Ion Optix photometry system was used to measure the levels of intracellular Ca 2+ transients in cardiomyocytes isolated from JPH2 knock down mice. Results: We report that (i) JPH2 interacts with RyR2 and (ii) the C terminus of the JPH2 protein can pull down RyR2 receptors. Confocal immunofluorescence imaging indicated that the majority of JPH2 and RyR2 proteins were colocalized near Z-lines. A decrease in the levels of JPH2 expression reduced the amplitude of Ca 2+ transients in cardiomyocytes. Conclusions: This study suggests that the C terminus domain of JPH2 is required for interactions with RyR2 in the context of peripheral coupling of mouse cardiomyocytes, which provide a molecular mechanism for looking for Ca 2+ - related diseases prevention strategies.

Cell Calcium ◽  
2003 ◽  
Vol 34 (3) ◽  
pp. 261-269 ◽  
Author(s):  
Jens H Westhoff ◽  
Sung-Yong Hwang ◽  
R Scott Duncan ◽  
Fumiko Ozawa ◽  
Pompeo Volpe ◽  
...  

Hypertension ◽  
2011 ◽  
Vol 58 (6) ◽  
pp. 1099-1110 ◽  
Author(s):  
Yunzeng Zou ◽  
Yanyan Liang ◽  
Hui Gong ◽  
Ning Zhou ◽  
Hong Ma ◽  
...  

2017 ◽  
Vol 58 (6) ◽  
pp. 957-961 ◽  
Author(s):  
Zhiwen Ding ◽  
Jie Yuan ◽  
Yanyan Liang ◽  
Jian Wu ◽  
Hui Gong ◽  
...  

2014 ◽  
Vol 103 (1) ◽  
pp. 178-187 ◽  
Author(s):  
David Y. Chiang ◽  
Na Li ◽  
Qiongling Wang ◽  
Katherina M. Alsina ◽  
Ann P. Quick ◽  
...  

2013 ◽  
Vol 34 (suppl 1) ◽  
pp. P5016-P5016
Author(s):  
D. Y. Chiang ◽  
N. Li ◽  
G. Wang ◽  
Q. Wang ◽  
A. Quick ◽  
...  

2007 ◽  
Vol 282 (45) ◽  
pp. 32877-32889 ◽  
Author(s):  
Sunoh Kim ◽  
Hyung-Mun Yun ◽  
Ja-Hyun Baik ◽  
Kwang Chul Chung ◽  
Seung-Yeol Nah ◽  
...  

Neuroreport ◽  
1999 ◽  
Vol 10 (3) ◽  
pp. 481-486 ◽  
Author(s):  
Mauricio Díaz-Muñoz ◽  
Myrna A. R. Dent ◽  
Daniel Granados-Fuentes ◽  
Adam C. Hall ◽  
Arturo Hernández-Cruz ◽  
...  

2013 ◽  
Vol 24 (4) ◽  
pp. 741-744 ◽  
Author(s):  
Wolfgang Lawrenz ◽  
Otto N. Krogmann ◽  
Marcus Wieczorek

AbstractCatecholaminergic polymorphic ventricular tachycardia is a rare life-threatening arrhythmogenic disorder. An association with paroxysmal atrial fibrillation and other atrial arrhythmias has been described, but in all published cases the initial manifestation of the disease was ventricular arrhythmia. This is the first report about a patient who presented with complex atrial tachycardia and sinus node dysfunction about 1 year before the typical ventricular arrhythmias were observed, leading to the diagnosis of catecholaminergic polymorphic ventricular tachycardia. In this girl, a mutation of the ryanodine receptor type 2 gene, which has not been described so far, was discovered.


Sign in / Sign up

Export Citation Format

Share Document